-
Study aim
-
Investigating the effect of Plantago major on clinical symptoms of Ulcerative colitis
-
Design
-
Double blind clinical trial.The eligible persons of patients with symptoms of Ulcerative colitis, that confirmed by colonoscopy and biopsy, will be chosen and then will be randomly categorized into intervention or control group.Finally,the effect of Plantago major on severity of disease symptoms will be evaluated.Intervention group:Prescribed chemical drugs with Plantago major and Control group: Prescribed chemical drugs with placebo.Sample size:50 Phase:3
-
Settings and conduct
-
Site:Gastroentrology clinic, Imam Khomeiny hospital, Urmia.General Mizaj in 0, 8 w., Severity of symptoms in 0, 4, 8 w. according to Lichtiger Clinical Index,and Drug side effects in 4, 8 w.,will be evaluated.Research fellow and participants are blinded to drug type.
-
Participants/Inclusion and exclusion criteria
-
Include:1.Having the clinical symptoms of Ulcerative colitis that confirmed by endoscopy and biopsy2.Age 15-70 years Exclude:1.Pregnancy or breast feeding2.Massive bleeding or need to hospitalization or emergent surgery3.Fulminant colitis, Peritonitis, Toxic megacolon, Colorectal cancer, Stricture, Obstruction4.Using of Antibiotics, Herbal drugs,OCPs, NSAIDs or Hormonal therapy(in last 2 weeks(w.))5.Concurrent important and severe disease:liver, kidney or heart disease, cancer or Celiac disease6.Cigarette or opioids addiction
-
Intervention groups
-
Intervention group: Capsule 600mg of Plantago major roasted seed, 2 cap. 30 minutes before meals(totally 6 cap. in day), up to 8 w. and Control group: Capsule 600mg of roasted Wheat flour, 2 cap. 30 minuts before meals(totally 6 cap. in day), up to 8 w..All of the patients have their prescript chemical drugs.
-
Main outcome variables
-
Severity of clinical symptoms of Ulcerative colitis (remission, mild, moderate, sever)